Testing a laser procedure to control eye pressure in newly diagnosed glaucoma

This trial is testing DSLT (diode selective laser trabeculoplasty), a laser procedure, as a first-line treatment for people newly diagnosed with mild to moderate open angle glaucoma. The goal is to see whether the treatment can help keep eye pressure controlled without requiring patients to use daily glaucoma medications. Researchers want to understand how well this laser procedure works when used as the first treatment for newly diagnosed patients.

Many glaucoma patients need to take daily eye drops for the rest of their lives to manage their condition, which can be inconvenient and burdensome. This trial exists to explore whether this laser treatment could be an effective alternative that helps control eye pressure while reducing or eliminating the need for daily medications.